In Canada, an estimated 5400 deaths attributable to AMR occurred in 2018.1 By 2050, 40% of infections will be resistant to first-line antimicrobials.1 The pan-Canadian action plan on AMR has outlined ...
Solutions are needed in Canada to meet the health care needs of the growing number of adults with complex genetic neurodevelopmental conditions who have aged out of pediatric systems into adult ...
Access to health care: Emergency department use before cancer diagnosis in Ontario, Canada: a population-based study ...
The syndrome of thrombocytopenia, anasarca, reticulin fibrosis, renal dysfunction, organomegaly (TAFRO) is a rare subtype of idiopathic multicentric Castleman disease. This syndrome should be ...
In Canada and Alberta, there is a long-standing history of tension between primary health care and the acute care system. The Primary Health Care Integration Network is a shared space for ...
Access to health care: Diagnosis and management of early pregnancy loss ...
Background: Standard pharmacotherapy for patients with heart failure with reduced ejection fraction (HFrEF) comprises “quadruple therapy” with a renin–angiotensin system inhibitor, a β-blocker, a ...
Early pregnancy loss, also known as miscarriage, is common, distressing, and frequently poorly managed in Canada. Diagnosis of early pregnancy loss requires determination of serum β-human chorionic ...
Heart failure is an increasingly common and fatal disease and causes a heavy patient, health care–system, and cost burden. A cost-effectiveness study looking at different scenarios of achieving ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback